EGFR—TKI在非小细胞肺癌中的耐药机制及治疗研究进展(3)
[2] Wang J，Wang B，Chu H，et al.Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations[J].OncoTargets and Therapy，2016，9：3711-3726.[3] Seo J S，Ju Y S，Lee W C，et al.The transcriptional landscape and mutational profile of lung adenocarcinoma[J].Genome Research ......
您现在查看是摘要页，全文长 2593 字符。